Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Ischemic Heart Disease

Free Subscription Articles published in J Mol Cell Cardiol Retrieve available abstracts of 44 articles: HTML format

Single Articles

December 2025
1. SANCHEZ-LOPEZ D, Garcia-Vega D, Vinuela JE, Ferreiros-Vidal I, et al
   Corrigendum to 'FABP4, marker of worse prognosis in cardiovascular disease, induces neutrophil's proatherogenic phenotype which is modulated by semaglutide' [Journal of Molecular and Cellular Cardiology volume 210 (2026) 12-27].
   J Mol Cell Cardiol. 2025;211:63.
   PubMed    
   
   
   
2. CHU Y, Zhu J, Chen S, Lin X, et al
   Beneficial effects of aryl hydrocarbon receptor activation on post-infarction myocardial metabolism, inflammation and fibrosis: implications from multi-omics.
   J Mol Cell Cardiol. 2025;209:104-118.
   PubMed     Abstract available
   
   
   November 2025
3. ZHAO L, Cao Y, Liu X, Yang Q, et al
   ZIP14 upregulation leads to ferroptosis and lysosomal dysfunction through intracellular iron overload and induces myocardial ischemia/reperfusion injury in mouse hearts.
   J Mol Cell Cardiol. 2025 Nov 27:S0022-2828(25)00219.
   PubMed     Abstract available
   
   
   
4. WONG D, Tran M, Martinez J, Avila I, et al
   Slit2-robo signaling regulates angiogenesis and repair following myocardial infarction.
   J Mol Cell Cardiol. 2025;210:28-42.
   PubMed     Abstract available
   
   
   
5. SANCHEZ-LOPEZ D, Garcia-Vega D, Vinuela JE, Ferreiros-Vidal I, et al
   FABP4, marker of worse prognosis in cardiovascular disease, induces neutrophil's proatherogenic phenotype which is modulated by semaglutide.
   J Mol Cell Cardiol. 2025 Nov 1:S0022-2828(25)00193.
   PubMed     Abstract available
   
   
   October 2025
6. SHUMLIAKIVSKA M, Fischer A, Muhly-Reinholz M, Leonard VE, et al
   The long non-coding RNA Snhg15 protects the heart after myocardial infarction.
   J Mol Cell Cardiol. 2025 Oct 27:S0022-2828(25)00195.
   PubMed     Abstract available
   
   
   
7. WANG Y, Li Y, Zhou Y, Zhang H, et al
   Nynrin enhances cardiac function by inhibiting mitochondrial permeability transition pore opening upon myocardial ischemia/reperfusion injury.
   J Mol Cell Cardiol. 2025 Oct 10:S0022-2828(25)00180.
   PubMed     Abstract available
   
   
   
8. SUN Z, Li N, Huang M, Li Y, et al
   Myofibroblast specific knockdown of NSUN2 suppresses cardiac fibrosis post-myocardial infarction.
   J Mol Cell Cardiol. 2025;209:27-36.
   PubMed     Abstract available
   
   
   
9. ALI SR, Nguyen NUN, Elhelaly W, Hsu CC, et al
   Paracrine IGFBP3 spatially coordinates IGF signaling to induce myocardial regeneration in mice.
   J Mol Cell Cardiol. 2025;207:93-106.
   PubMed     Abstract available
   
   
   September 2025
10. THOMAS D, Yang PC, Wu JC, Sayed N, et al
    Decoding long COVID-associated cardiovascular dysfunction: Mechanisms, models, and new approach methodologies.
    J Mol Cell Cardiol. 2025 Sep 30:S0022-2828(25)00178.
    PubMed     Abstract available
    
    
    
11. CHOI JS, Pervin M, Vince JE, Sharma A, et al
    Targeting the NLRP3 Inflammasome-Gasdermin D Axis to Combat Cardiovascular Diseases.
    J Mol Cell Cardiol. 2025;209:1-14.
    PubMed     Abstract available
    
    
    
12. CHEN Z, Yu X, Ke M, Li H, et al
    Corrigendum to "Human embryonic stem cell-derived cardiovascular progenitor cells stimulate cardiomyocyte cell cycle activity via activating the PI3K/Akt pathway" [J. Mol. Cell. Cardiol. 197 (2024) 5-10.].
    J Mol Cell Cardiol. 2025;208:32-34.
    PubMed    
    
    
    
13. JIANG Y, Estau D, Qiao Y, Li Z, et al
    14-3-3/HIP-55 complex attenuates cardiomyocyte apoptosis.
    J Mol Cell Cardiol. 2025;206:91-101.
    PubMed     Abstract available
    
    
    July 2025
14. WELLS CK, Nguyen DC, Brainard RE, McNally LA, et al
    Pyruvate kinase splice variants in fibroblasts influence cardiac remodeling after myocardial infarction in male mice.
    J Mol Cell Cardiol. 2025;206:11-26.
    PubMed     Abstract available
    
    
    
15. MELKANI GC
    Time-restricted feeding mediated synchronization of circadian rhythms to sustain cardiovascular health.
    J Mol Cell Cardiol. 2025;206:1-10.
    PubMed     Abstract available
    
    
    
16. GIBBS CE, Boyle PM
    Population-based computational simulations elucidate mechanisms of focal arrhythmia following stem cell injection.
    J Mol Cell Cardiol. 2025;204:5-16.
    PubMed     Abstract available
    
    
    April 2025
17. SEVERINO P, D'Amato A, Prosperi S, Myftari V, et al
    Coronary microcirculation in myocardial ischemia: A genetic perspective.
    J Mol Cell Cardiol. 2025 Apr 10:S0022-2828(25)00060.
    PubMed     Abstract available
    
    
    March 2025
18. PYLE WG
    Heartbreak and trauma: Unraveling sex-specific effects of post-traumatic stress disorder on cardiovascular disease.
    J Mol Cell Cardiol. 2025;202:153-154.
    PubMed    
    
    
    
19. GASPAR LS, Pyakurel S, Xu N, D'Souza SP, et al
    Circadian biology in obstructive sleep apnea associated cardiovascular disease.
    J Mol Cell Cardiol. 2025 Mar 17:S0022-2828(25)00054.
    PubMed     Abstract available
    
    
    
20. ROBERTS TD, Hutchinson DS, Wootten D, De Blasio MJ, et al
    Advances in incretin therapies for targeting cardiovascular disease in diabetes.
    J Mol Cell Cardiol. 2025;202:102-115.
    PubMed     Abstract available
    
    
    January 2025
21. SHABANI P, Dong F, Yun J, Shin SY, et al
    Does coronary microvascular dysfunction play a role in heart failure with reduced ejection fraction?
    J Mol Cell Cardiol. 2025 Jan 28:S0022-2828(25)00007.
    PubMed     Abstract available
    
    
    
22. AUDAM TN, Howard CM, Little DT, Garrett LF, et al
    Hyaluronan provokes inflammation but suppresses phagocytotic function in macrophages.
    J Mol Cell Cardiol. 2025;198:24-35.
    PubMed     Abstract available
    
    
    December 2024
23. FLORES RC, Yaffe R, Nhunzwi MM, Nguyen H, et al
    Maternal shift work during pregnancy and cardiovascular health impacts on mother and offspring.
    J Mol Cell Cardiol. 2024 Dec 21:S0022-2828(24)00213.
    PubMed     Abstract available
    
    
    
24. HYTONEN JP, Pajula J, Halonen P, Taavitsainen J, et al
    Endothelialization of coronary stents after intra-luminal adenoviral VEGF-A gene transfer in a preclinical porcine restenosis model - Studies with optical coherence tomography, angioscopy, multiphoton and scanning electron microscopy.
    J Mol Cell Cardiol. 2024 Dec 18:S0022-2828(24)00212.
    PubMed     Abstract available
    
    
    November 2024
25. BASSIOUNI W, Mahmud Z, Simmen T, Seubert JM, et al
    MMP-2 inhibition attenuates ER stress-mediated cell death during myocardial ischemia-reperfusion injury by preserving IRE1alpha.
    J Mol Cell Cardiol. 2024;198:74-88.
    PubMed     Abstract available
    
    
    
26. JIMENEZ-TELLEZ N, Williams D, Liu Y, Wang M, et al
    Transcriptomic analysis of nicotine on the cardiovascular system using a diverse population of human induced pluripotent stem cell-derived endothelial cells.
    J Mol Cell Cardiol. 2024;198:21-23.
    PubMed    
    
    
    
27. LI R, Hanna A, Huang S, Hernandez SC, et al
    Macrophages in the infarcted heart acquire a fibrogenic phenotype, expressing matricellular proteins, but do not undergo fibroblast conversion.
    J Mol Cell Cardiol. 2024;196:152-167.
    PubMed     Abstract available
    
    
    October 2024
28. CHEN Z, Yu X, Ke M, Li H, et al
    Human embryonic stem cell-derived cardiovascular progenitor cells stimulate cardiomyocyte cell cycle activity via activating the PI3K/Akt pathway.
    J Mol Cell Cardiol. 2024 Oct 9:S0022-2828(24)00163.
    PubMed     Abstract available
    
    
    
29. STURNY R, Boulgakoff L, Kelly RG, Miquerol L, et al
    Transient formation of collaterals contributes to the restoration of the arterial tree during cardiac regeneration in neonatal mice.
    J Mol Cell Cardiol. 2024;195:1-13.
    PubMed     Abstract available
    
    
    September 2024
30. PENG Y, Jiang Y, Zhou Q, Jia Z, et al
    SGK1 contributes to ferroptosis in coronary heart disease through the NEDD4L/NF-kappaB pathway.
    J Mol Cell Cardiol. 2024 Sep 6:S0022-2828(24)00143.
    PubMed     Abstract available
    
    
    August 2024
31. GUTIERREZ-AGUILAR M, Klutho PJ, Aguayo-Ortiz R, Song L, et al
    Endogenous complement 1q binding protein (C1qbp) regulates mitochondrial permeability transition and post-myocardial infarction remodeling and dysfunction.
    J Mol Cell Cardiol. 2024 Aug 27:S0022-2828(24)00140.
    PubMed     Abstract available
    
    
    
32. YI J, Chen K, Cao Y, Wen C, et al
    Up-regulated novel-miR-17 promotes hypothermic reperfusion arrhythmias by negatively targeting Gja1 and mediating activation of the PKC/c-Jun signaling pathway.
    J Mol Cell Cardiol. 2024;193:1-10.
    PubMed     Abstract available
    
    
    July 2024
33. LAHIRI SK, Lu J, Aguilar-Sanchez Y, Li H, et al
    Targeting Calpain-2-mediated Junctophilin-2 cleavage delays heart failure progression following myocardial infarction.
    J Mol Cell Cardiol. 2024 Jul 1:S0022-2828(24)00108.
    PubMed     Abstract available
    
    
    June 2024
34. SENTHILKUMAR G, Hammond ST, Zirgibel Z, Cohen KE, et al
    Is the peripheral microcirculation a window into the human coronary microvasculature?
    J Mol Cell Cardiol. 2024;193:67-77.
    PubMed     Abstract available
    
    
    May 2024
35. KISKIN FN, Yang Y, Yang H, Zhang JZ, et al
    Cracking the code of the cardiovascular enigma: hPSC-derived endothelial cells unveil the secrets of endothelial dysfunction.
    J Mol Cell Cardiol. 2024;192:65-78.
    PubMed     Abstract available
    
    
    
36. MCCALLINHART PE, Chade AR, Bender SB, Trask AJ, et al
    Expanding landscape of coronary microvascular disease in co-morbid conditions: Metabolic disease and beyond.
    J Mol Cell Cardiol. 2024;192:26-35.
    PubMed     Abstract available
    
    
    
37. DE WINTER N, Ji J, Sintou A, Forte E, et al
    Persistent transcriptional changes in cardiac adaptive immune cells following myocardial infarction: New evidence from the re-analysis of publicly available single cell and nuclei RNA-sequencing data sets.
    J Mol Cell Cardiol. 2024;192:48-64.
    PubMed     Abstract available
    
    
    
38. MA X, Zhao J, Feng Y
    Epicardial SMARCA4 deletion exacerbates cardiac injury in myocardial infarction and is related to the inhibition of epicardial epithelial-mesenchymal transition.
    J Mol Cell Cardiol. 2024;191:76-87.
    PubMed     Abstract available
    
    
    
39. SUN H, Wang X, Pratt RE, Dzau VJ, et al
    C166 EVs potentiate miR cardiac reprogramming via miR-148a-3p.
    J Mol Cell Cardiol. 2024;190:48-61.
    PubMed     Abstract available
    
    
    April 2024
40. CREA F, Iannaccone G, La Vecchia G, Montone RA, et al
    An update on the mechanisms of Takotsubo syndrome: "At the end an acute coronary syndrome".
    J Mol Cell Cardiol. 2024 Apr 17:S0022-2828(24)00053.
    PubMed     Abstract available
    
    
    March 2024
41. DU C, Zhao S, Shan T, Han X, et al
    Cellular nucleic acid binding protein facilitates cardiac repair after myocardial infarction by activating beta-catenin signaling.
    J Mol Cell Cardiol. 2024;189:66-82.
    PubMed     Abstract available
    
    
    
42. NGUYEN T, Rosa-Garrido M, Sadek H, Garry DJ, et al
    Promoting cardiomyocyte proliferation for myocardial regeneration in large mammals.
    J Mol Cell Cardiol. 2024;188:52-60.
    PubMed     Abstract available
    
    
    
43. CAO X, Thomas D, Whitcomb LA, Wang M, et al
    Modeling ionizing radiation-induced cardiovascular dysfunction with human iPSC-derived engineered heart tissues.
    J Mol Cell Cardiol. 2024;188:105-107.
    PubMed    
    
    
    February 2024
44. ANTIPENKO S, Mayfield N, Jinno M, Gunzer M, et al
    Neutrophils are indispensable for adverse cardiac remodeling in heart failure.
    J Mol Cell Cardiol. 2024;189:1-11.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge.